217 related articles for article (PubMed ID: 437918)
1. Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.
Minami A; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Int J Cancer; 1979 Mar; 23(3):358-65. PubMed ID: 437918
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
[TBL] [Abstract][Full Text] [Related]
3. Analysis of immunosuppressor cells induced by immunization of solubilized tumor-associated antigens prepared from a rat fibrosarcoma.
Minami A
Nihon Seikeigeka Gakkai Zasshi; 1981 Aug; 55(8):779-92. PubMed ID: 6171602
[TBL] [Abstract][Full Text] [Related]
4. Detection of delayed hypersensitivity reaction in rats by radioisotopic footpad assay with sodium deoxycholate extract and mitomycin-C-treated tumor cells.
Yamada Y; Mizushima Y; Hosokawa M; Kobayashi H
Gan; 1978 Aug; 69(4):549-55. PubMed ID: 81787
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan.
Mizushima Y; Sendo F; Takeichi N; Hosohawa M; Kobayashi H
Cancer Res; 1981 Jul; 41(7):2917-21. PubMed ID: 6454480
[TBL] [Abstract][Full Text] [Related]
6. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
[No Abstract] [Full Text] [Related]
7. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
8. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
Frbes JT; Nakaw Y; Smith RT
J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
[TBL] [Abstract][Full Text] [Related]
9. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
[TBL] [Abstract][Full Text] [Related]
10. Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery.
Shibata T; Suzuki K; Yamashita T; Takeichi N; Mark M; Hosokawa M; Kobayashi H; Arisue M
Anticancer Res; 1998; 18(4A):2483-6. PubMed ID: 9703896
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to soluble tumor antigens in various stages of tumor growth.
Brannen GE; Santos GW
Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the radioisotopic footpad assay and other immunological assays in tumor bearing rats.
Mizushima Y; Takeichi N; Minami A; Kasai M; Itaya T; Yamaguchi H; Kobayashi H
Tohoku J Exp Med; 1981 Mar; 133(3):331-7. PubMed ID: 7314087
[TBL] [Abstract][Full Text] [Related]
13. Change of antigenic expression on rat tumor cells after their transplantation.
Gotohda E; Sendo F; Nakayama M; Hosokawa M; Kawamura T
J Natl Cancer Inst; 1975 Nov; 55(5):1079-83. PubMed ID: 1206734
[TBL] [Abstract][Full Text] [Related]
14. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
Poupon MF; Lespinats G; Kolb JP; Payelle B
J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
Mizushima Y; Sendo F; Miyake T; Kobayashi H
J Natl Cancer Inst; 1981 Apr; 66(4):659-65. PubMed ID: 6939913
[TBL] [Abstract][Full Text] [Related]
16. Tumor resistance in rats immunized to fetal tissues.
Grant JP; Wells SA
J Surg Res; 1974 May; 16(5):533-40. PubMed ID: 4831730
[No Abstract] [Full Text] [Related]
17. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
Brannen GE; Adams JS; Santos GW
J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
[No Abstract] [Full Text] [Related]
19. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
Hellström KE; Hellström I
Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts.
Hosokawa M; Imamura M; Oikawa T; Nakayama M; Gotohda E; Sendo F; Kodama T; Kobayashi H
Int J Cancer; 1976 Sep; 18(3):369-74. PubMed ID: 783054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
